![Marc Chamberlain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Marc Chamberlain currently works at Lantern Pharma, Inc., as Chief Medical Officer-Starlight Therapeutics from 2023.
Dr. Chamberlain also formerly worked at Seagen, Inc., as Medical Director, Cascadian Therapeutics LLC, as Medical Director, Angiochem, Inc., as Medical Director, and Pionyr Immunotherapeutics, Inc., as Medical Director.
Marc Chamberlain active positions
| Companies | Position | Start |
|---|---|---|
| LANTERN PHARMA INC. | Corporate Officer/Principal | 31/10/2023 |
Former positions of Marc Chamberlain
| Companies | Position | End |
|---|---|---|
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Corporate Officer/Principal | - |
| SEAGEN INC. | Corporate Officer/Principal | - |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Corporate Officer/Principal | - |
| CASCADIAN THERAPEUTICS INC (USA) | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Health Technology |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Health Technology |
Lantern Pharma, Inc.
 Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
- Stock Market
- Insiders
- Marc Chamberlain
